AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Smallpox Vaccine Supplied to US Government for Strategic National Stockpile Receives Positive Vote From Panel of Infectious Disease and Vaccine Experts
CAMBRIDGE, England and CAMBRIDGE, Massachusetts, May 17 /PRNewswire-FirstCall/ -- Acambis plc (Acambis) , a leading biotechnology company targeting infectious diseases with novel vaccines, announces that the Vaccines and Related Biological Products Advisory Committee of the US Food and Drug Administration (FDA) today voted unanimously that Acambis' smallpox vaccine, ACAM2000, is both safe and efficacious.
The Advisory Committee was asked to review whether the efficacy and safety data were sufficient to support the use of ACAM2000 in situations where it is determined that there is high risk of exposure to smallpox virus. At a meeting held in Gaithersburg, Maryland, the panel voted 11-0 in favor on both the safety and efficacy of ACAM2000.
The Advisory Committee provides the FDA with independent, non-binding advice from outside experts on issues related…
Source: HighBeam Research, FDA Advisory Committee Unanimously Votes in Favor of Acambis'...